"Cardiologists at this location: Nasser A. Chaudhry, MD Rozy D. Dunham, MD Mitchell Fuhrman, MD, FACC Scott J. Gabler, MD Jayesh R. Khatiwala, MD David L. Lawrence, MD Robert A. Mohapatra, MD Bryan E. Saia, DO Vivek V. Sailam, MD Jason Smith, DO"

During the past decade, Lourdes Cardiology Services conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 14 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lourdes Cardiology Services" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 12 trials, followed by "Abbott Medical Devices" with 7 trials sponsored, "Pfizer" with 2 trials sponsored, "Angel Medical Systems" with 1 trials sponsored and "Astellas Pharma Inc" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lourdes Cardiology Services" #1 collaborator was "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Lourdes Cardiology Services" are "Heart Failure" (9 trials), "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials) and "Heart Failure NYHA Class II" (2 trials). Many other conditions were trialed in "Lourdes Cardiology Services" in a lesser frequency.

Most popular intervention types in "Lourdes Cardiology Services" are "Device" (19 trials), "Drug" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "ASP1128" (1 trials), "Any Abiomed Impella® device approved for use in high-risk PCI" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lourdes Cardiology Services" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Lourdes Cardiology Services". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Lourdes Cardiology Services, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Lourdes Cardiology Services, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".